GlassScriptPhysician profile
Donna Cassell
NPI 1760476857
$3,372.38
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $547 · 2021: $613 · 2022: $666 · 2023: $385 · 2024: $54.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.39 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,582.10 | 2019-2024 | Trelegy Ellipta, Nucala |
| Actelion Pharmaceuticals US, INC. | $461.46 | 2019-2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $308.85 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.66 | 2019-2023 | Ofev |
| United Therapeutics Corporation | $116.95 | 2019 | |
| Mylan Specialty L.P. | $80.33 | 2019-2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $77.24 | 2021-2022 | |
| Genzyme Corporation | $68.63 | 2021-2023 | |
| Gilead Sciences, INC. | $62.86 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $56.24 | 2019 | |
| Genentech USA, INC. | $51.90 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $49.11 | 2021-2023 | Dupixent |
| Mallinckrodt Hospital Products INC. | $48.31 | 2021 | |
| Merck Sharp & Dohme LLC | $34.96 | 2019-2022 | |
| Insmed, INC. | $32.48 | 2022-2024 | Arikayce |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $18.11 | 2022 | |
| Boston Scientific Corporation | $16.57 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.42 | 2022 | |
| La Jolla Pharmaceutical Company | $12.60 | 2020 | |
| Allergan, INC. | $12.55 | 2020 | |
| Grifols USA, LLC | $11.75 | 2020 | |
| Pfizer INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Cassell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.